| Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor … S Moshkelgosha, PW So, N Deasy, S Diaz-Cano, JP Banga Endocrinology 154 (9), 3008-3015, 2013 | 126 | 2013 |
| Gut microbiota in experimental murine model of Graves’ orbitopathy established in different environments may modulate clinical presentation of disease G Masetti, S Moshkelgosha, HL Köhling, D Covelli, JP Banga, ... Microbiome 6, 1-15, 2018 | 79 | 2018 |
| Comparative assessment of female mouse model of Graves' orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin … U Berchner-Pfannschmidt, S Moshkelgosha, S Diaz-Cano, B Edelmann, ... Endocrinology 157 (4), 1673-1682, 2016 | 61 | 2016 |
| Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation … L Levy, E Huszti, B Renaud-Picard, G Berra, M Kawashima, A Takahagi, ... The Journal of Heart and Lung Transplantation 39 (8), 761-770, 2020 | 56 | 2020 |
| Modeling Graves’ Orbitopathy in Experimental Graves’ Disease JP Banga, S Moshkelgosha, U Berchner-Pfannschmidt, A Eckstein | 54 | 2015 |
| Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease S Moshkelgosha, HL Verhasselt, G Masetti, D Covelli, F Biscarini, ... Microbiome 9, 1-20, 2021 | 50 | 2021 |
| Gut microbiome in BALB/c and C57BL/6J mice undergoing experimental thyroid autoimmunity associate with differences in immunological responses and thyroid function S Moshkelgosha, G Masetti, U Berchner-Pfannschmidt, HL Verhasselt, ... Hormone and Metabolic Research 50 (12), 932-941, 2018 | 47 | 2018 |
| Extracellular matrix injury of kidney allografts in antibody-mediated rejection: a proteomics study S Clotet-Freixas, CM McEvoy, I Batruch, C Pastrello, M Kotlyar, JAD Van, ... Journal of the American Society of Nephrology 31 (11), 2705-2724, 2020 | 36 | 2020 |
| Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration CYK Zhang, M Ahmed, E Huszti, L Levy, SE Hunter, KM Boonstra, ... The Journal of Heart and Lung Transplantation 39 (9), 934-944, 2020 | 25 | 2020 |
| Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin RVP Ribeiro, T Ku, A Wang, L Pires, VH Ferreira, V Michaelsen, A Ali, ... The Journal of Heart and Lung Transplantation 41 (3), 287-297, 2022 | 22 | 2022 |
| Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients—a single‐center … L Levy, A Tigert, E Huszti, T Saito, N Mitsakakis, S Moshkelgosha, B Joe, ... Transplant International 32 (9), 965-973, 2019 | 22 | 2019 |
| Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female Graves’ orbitopathy mouse model GE Görtz, S Moshkelgosha, C Jesenek, B Edelmann, M Horstmann, ... Endocrinology 157 (10), 3771-3778, 2016 | 17 | 2016 |
| Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation S Moshkelgosha, A Duong, G Wilson, T Andrews, G Berra, ... The Journal of Heart and Lung Transplantation 41 (11), 1556-1569, 2022 | 13 | 2022 |
| Preclinical models of Graves’ disease and associated secondary complications S Moshkelgosha, PW So, S Diaz-Cano, J Paul Banga Current Pharmaceutical Design 21 (18), 2414-2421, 2015 | 9 | 2015 |
| Autologous hematopoietic stem cell transplantation for liver transplant recipients with recurrent primary sclerosing cholangitis: a pilot study A Chruscinski, S Juvet, S Moshkelgosha, E Renner, L Lilly, N Selzner, ... Transplantation 106 (3), 562-574, 2022 | 8 | 2022 |
| Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients L Levy, E Huszti, M Ahmed, R Ghany, S Hunter, S Moshkelgosha, ... The Journal of Heart and Lung Transplantation 40 (12), 1540-1549, 2021 | 8 | 2021 |
| IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome P Riddell, S Moshkelgosha, L Levy, N Chang, P Pal, K Halloran, ... Clinical & Translational Immunology 10 (2), e1243, 2021 | 7 | 2021 |
| CTOT-20 investigators. Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration CYK Zhang, M Ahmed, E Huszti, L Levy, SE Hunter, KM Boonstra, ... J Heart Lung Transplant 39 (09), 934-944, 2020 | 6 | 2020 |
| Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial A Chruscinski, V Rojas-Luengas, S Moshkelgosha, A Issachar, J Luo, ... Clinical and Experimental Immunology 207 (1), 123-139, 2022 | 4 | 2022 |
| Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction L Levy, S Moshkelgosha, E Huszti, S Hunter, B Renaud-Picard, G Berra, ... The Journal of Heart and Lung Transplantation 42 (8), 1152-1160, 2023 | 3 | 2023 |
